This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 May 29;145(22):2542.

doi: 10.1182/blood.2024028272.

Guidance on the interpretation of CRBN mutations in myeloma

K Martin Kortüm¹, Hermann Einsele¹

Affiliations

PMID: 40440041
DOI: 10.1182/blood.2024028272

Editorial

Guidance on the interpretation of CRBN mutations in myeloma

K Martin Kortüm et al. Blood. 2025.

. 2025 May 29;145(22):2542.

doi: 10.1182/blood.2024028272.

Authors

K Martin Kortüm¹, Hermann Einsele¹

Affiliation

¹ University Hospital Würzburg.

PMID: 40440041
DOI: 10.1182/blood.2024028272

No abstract available

PubMed Disclaimer

Comment on

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma.
Chrisochoidou Y, Scarpino A, Morales S, Martin S, Bird S, Li Y, Walker B, Caldwell J, Le Bihan YV, Pawlyn C. Chrisochoidou Y, et al. Blood. 2025 May 29;145(22):2630-2644. doi: 10.1182/blood.2024025861. Blood. 2025. PMID: 39841463 Free PMC article.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems